The safety profile of tadalafil as prescribed in
general practice in England: results from a
prescription-event monitoring study involving
16 129 patients
The safety profile of tadalafil as prescribed in
general practice in England: results from a
prescription-event monitoring study involving
16 129 patients
Objectives: to examine the safety of tadalafil as used in general practice in England, and to compare the mortality rate due to ischaemic heart disease (IHD) in tadalafil users with that in the male population in England.
Patients and methods: patients in this observational cohort study were identified from dispensed prescriptions for tadalafil issued by general practitioners (GPs) from February 2003 to November 2004. Demographic and outcome data (clinical events) were requested from patients’ GPs using a postal questionnaire. A standardized mortality ratio (SMR) was calculated using indirect standardization for deaths from IHD in the cohort (where age was known) over a 1-year observation period compared to that in the English male population (2003). A sensitivity analysis was carried out to investigate the effects of missing data for age and cause of death.
Results: clinical information was obtained for 16 129 patients (median age 60 years, interquartile range 52–67); the age was not specified for 3212 (19.9%) patients. At least a third of the patients had diabetes mellitus and 29% had hypertension. Comparison of the mortality rate due to IHD for the patients of known age with that in the English male population provided an SMR of 0.57 (95% confidence interval 0.38–0.83) indicating fewer observed deaths in the cohort than expected. The results of the sensitivity analyses investigating the effect of missing data for age and cause of death produced similar SMR estimates. One confirmed case of non-arteritic anterior ischaemic optic neuropathy (NAION) was reported during tadalafil therapy in a patient with other risk factors for this condition.
Conclusion: the results from this prescription-event monitoring study suggest that tadalafil is generally
tadalafil, mortality, postmarketing surveillance, prescription-event monitoring, myocardial infarction, ischaemic heart disease
506-514
Cornelius, Victoria
b75c21d7-2c25-495c-9107-e39453a72bdd
Hazell, Laura
cf6bb05b-4dcd-4f3f-8353-8473c80639d7
Wilton, Lynda V.
256cf2df-2315-4a38-b928-d67e5517f7cf
Shakir, Saad A.W.
648f9207-b801-4dc9-9f7f-b694bb4dc518
February 2009
Cornelius, Victoria
b75c21d7-2c25-495c-9107-e39453a72bdd
Hazell, Laura
cf6bb05b-4dcd-4f3f-8353-8473c80639d7
Wilton, Lynda V.
256cf2df-2315-4a38-b928-d67e5517f7cf
Shakir, Saad A.W.
648f9207-b801-4dc9-9f7f-b694bb4dc518
Cornelius, Victoria, Hazell, Laura, Wilton, Lynda V. and Shakir, Saad A.W.
(2009)
The safety profile of tadalafil as prescribed in
general practice in England: results from a
prescription-event monitoring study involving
16 129 patients.
BJU International, 103 (4), .
(doi:10.1111/j.1464-410X.2008.08000.x).
Abstract
Objectives: to examine the safety of tadalafil as used in general practice in England, and to compare the mortality rate due to ischaemic heart disease (IHD) in tadalafil users with that in the male population in England.
Patients and methods: patients in this observational cohort study were identified from dispensed prescriptions for tadalafil issued by general practitioners (GPs) from February 2003 to November 2004. Demographic and outcome data (clinical events) were requested from patients’ GPs using a postal questionnaire. A standardized mortality ratio (SMR) was calculated using indirect standardization for deaths from IHD in the cohort (where age was known) over a 1-year observation period compared to that in the English male population (2003). A sensitivity analysis was carried out to investigate the effects of missing data for age and cause of death.
Results: clinical information was obtained for 16 129 patients (median age 60 years, interquartile range 52–67); the age was not specified for 3212 (19.9%) patients. At least a third of the patients had diabetes mellitus and 29% had hypertension. Comparison of the mortality rate due to IHD for the patients of known age with that in the English male population provided an SMR of 0.57 (95% confidence interval 0.38–0.83) indicating fewer observed deaths in the cohort than expected. The results of the sensitivity analyses investigating the effect of missing data for age and cause of death produced similar SMR estimates. One confirmed case of non-arteritic anterior ischaemic optic neuropathy (NAION) was reported during tadalafil therapy in a patient with other risk factors for this condition.
Conclusion: the results from this prescription-event monitoring study suggest that tadalafil is generally
Restricted to Repository staff only
More information
Published date: February 2009
Keywords:
tadalafil, mortality, postmarketing surveillance, prescription-event monitoring, myocardial infarction, ischaemic heart disease
Identifiers
Local EPrints ID: 162023
URI: http://eprints.soton.ac.uk/id/eprint/162023
ISSN: 1464-4096
PURE UUID: 754b9350-5f5e-4e7d-ab82-6312380e7c0c
Catalogue record
Date deposited: 12 Aug 2010 07:59
Last modified: 14 Mar 2024 02:01
Export record
Altmetrics
Contributors
Author:
Victoria Cornelius
Author:
Laura Hazell
Author:
Lynda V. Wilton
Author:
Saad A.W. Shakir
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics